Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance

AstraZeneca plcTrade
KraneShares Hang Seng TECH Index ETFTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs KraneShares Hang Seng TECH Index ETF — how do they compare? AstraZeneca plc trades at $159.37 (market cap $250.84B), while KraneShares Hang Seng TECH Index ETF trades at $13.5. The key difference: AstraZeneca plc pays a 1.97% dividend while KraneShares Hang Seng TECH Index ETF pays none. Which is the better fit depends on your goals.

AZNKTEC
Market Cap
$250.84B
Sector
HealthSector/Thematic
52-Week High
$209.48$19.51
52-Week Low
$147.06$12.00
Enterprise Value
$278.12B
Dividend Yield
1.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AstraZeneca plc

AstraZeneca (AZN) trades at $161.42, up 0.22% today, amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth to $58.74B in 2025 and net income of $10.23B, supported by a P/E of 24.16 and robust profitability margins. Recent news highlights potential talks with Bristol Myers Squibb, though a senior source denied ongoing discussions (Reuters, 2026-08-05).

The outlook is mixed: solid earnings beats and a 47.5% analyst buy rating support upside, but technical weakness and merger uncertainty pose near-term risks. Long-term growth hinges on execution amid competitive and regulatory pressures, with the stock offering value if merger rumors subside and fundamentals prevail.

KraneShares Hang Seng TECH Index ETF

KTEC trades at $13.78, up 1.47% today, with a bullish technical signal driven by moving averages. Support and resistance cluster at $14, indicating a critical price zone. Financial ratios are unavailable, limiting fundamental clarity. Recent news highlights China's AI competition as a potential catalyst for tech ETFs like KTEC.

The stock's outlook hinges on AI sector momentum, but risks include reliance on thematic trends and lack of disclosed financials. Upside depends on broader tech ETF inflows, while volatility from geopolitical or market shifts poses a near-term challenge.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About KraneShares Hang Seng TECH Index ETF

KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.

Read more on KTEC